Drug Database
Back to search

Japan· JP-1143400A2017

サリチル酸ナトリウム

A sodium salicylate product containing サリチル酸ナトリウム, registered in Japan, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

On Japan’s NHI price listATC N02BA04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedサリチル酸ナトリウムATCN02BA04REGISTER NO.JP-1143400A2017PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about サリチル酸ナトリウムAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium salicylate is registered in 5 of 19 countries.

Countries holding a registration under ATC N02BA04 (sodium salicylate), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 3 of them publish a price we can compare per daily dose
Search sodium salicylate products by name

Sodium salicylate · ATC N02BA04

5 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
サリチル酸ナトリウム
Manufacturer
—
Country
Japan (JP)
ATC code
N02BA04
ATC class
Sodium salicylate
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium salicylate in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium salicylate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Czechia · Natrium Salicylicum Bbp
  • Slovakia · Natrium Salicylicum Bbp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa5a7c85-73bb-452d-bcb5-a6c2dc8d0b03
GET /v1/drugs/aa5a7c85-73bb-452d-bcb5-a6c2dc8d0b03?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５％１０ｍＬ１管",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1143400A2017",
  "category": "注射薬",
  "price_yen": 63,
  "generic_name": "サリチル酸ナトリウム",
  "product_name_jp": null,
  "therapeutic_class": "1143",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about sodium salicylate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console